Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 31 - 40 of 255 items for :

  • "estrogenic" x
Clear All
Henryk F Urbanski Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA
Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA
Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon, USA
Department of Physiology & Pharmacology, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Henryk F Urbanski in
Google Scholar
PubMed Close
,
Kevin Mueller Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA

Search for other papers by Kevin Mueller in
Google Scholar
PubMed Close
, and
Cynthia L Bethea Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA
Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA
Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Cynthia L Bethea in
Google Scholar
PubMed Close

Introduction Like elderly women, old female rhesus macaques show a marked decline in circulating E concentrations ( 1 ), and several monkey studies have demonstrated the therapeutic potential of E or a selective estrogen receptor modulator

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0108
Volume/Issue:
Volume 6: Issue 6
Open access
María J Gómora Departamento de Embriología, Facultad de Medicina, Universidad Nacional Autónoma de México, CdMx, Mexico

Search for other papers by María J Gómora in
Google Scholar
PubMed Close
,
Flavia Morales-Vásquez Departamento de Oncología Médica, Instituto Nacional de Cancerología, Secretaría de Salud de México, CdMx, Mexico

Search for other papers by Flavia Morales-Vásquez in
Google Scholar
PubMed Close
,
Enrique Pedernera Departamento de Embriología, Facultad de Medicina, Universidad Nacional Autónoma de México, CdMx, Mexico

Search for other papers by Enrique Pedernera in
Google Scholar
PubMed Close
,
Delia Perez-Montiel Departamento de Patología, Instituto Nacional de Cancerología, Secretaría de Salud de México, CdMx, Mexico

Search for other papers by Delia Perez-Montiel in
Google Scholar
PubMed Close
,
Horacio López-Basave Departamento de Cirugía Oncológica, Instituto Nacional de Cancerología, Secretaría de Salud de México, CdMx, Mexico

Search for other papers by Horacio López-Basave in
Google Scholar
PubMed Close
,
Antonio R Villa División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, CdMx, Mexico

Search for other papers by Antonio R Villa in
Google Scholar
PubMed Close
,
Azucena Hernández-Martínez Hospital Militar de Especialidades de la Mujer y Neonatología, Secretaría de la Defensa Nacional, CdMx, Mexico

Search for other papers by Azucena Hernández-Martínez in
Google Scholar
PubMed Close
,
Esteban Mena Unidad de Apoyo Académico, Secretaría General, Facultad de Medicina, Universidad Nacional Autónoma de México, CdMx, Mexico

Search for other papers by Esteban Mena in
Google Scholar
PubMed Close
, and
Carmen Mendez Departamento de Embriología, Facultad de Medicina, Universidad Nacional Autónoma de México, CdMx, Mexico

Search for other papers by Carmen Mendez in
Google Scholar
PubMed Close

migration and invasiveness, which are essential in tumor progression ( 11 , 12 , 13 , 14 ). The presence of androgen receptor (AR), estrogen receptor alpha (ER) and progesterone receptor (PR) plays an important role in the progression and treatment of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0158
Volume/Issue:
Volume 7: Issue 9
Open access
Martin Zweifel Department of Medical Oncology, University Hospital Bern, Bern, Switzerland

Search for other papers by Martin Zweifel in
Google Scholar
PubMed Close
,
Beat Thürlimann Breast Centre St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland

Search for other papers by Beat Thürlimann in
Google Scholar
PubMed Close
,
Salome Riniker Breast Centre St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland

Search for other papers by Salome Riniker in
Google Scholar
PubMed Close
,
Patrik Weder Breast Centre St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland

Search for other papers by Patrik Weder in
Google Scholar
PubMed Close
,
Roger von Moos Kantonsspital Graubünden, Chur, Switzerland

Search for other papers by Roger von Moos in
Google Scholar
PubMed Close
,
Olivia Pagani Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland

Search for other papers by Olivia Pagani in
Google Scholar
PubMed Close
,
Martin Bigler SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Martin Bigler in
Google Scholar
PubMed Close
,
Karin M Rothgiesser SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Karin M Rothgiesser in
Google Scholar
PubMed Close
,
Christiane Pilop SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Christiane Pilop in
Google Scholar
PubMed Close
,
Hanne Hawle SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Hanne Hawle in
Google Scholar
PubMed Close
,
Peter Brauchli SAKK Coordinating Centre, Bern, Switzerland

Search for other papers by Peter Brauchli in
Google Scholar
PubMed Close
,
Coya Tapia Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Coya Tapia in
Google Scholar
PubMed Close
,
Wolfgang Schoenfeld CURADIS GmbH, Erlangen, Germany

Search for other papers by Wolfgang Schoenfeld in
Google Scholar
PubMed Close
,
Cristiana Sessa Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland

Search for other papers by Cristiana Sessa in
Google Scholar
PubMed Close
, and
for the Swiss Group for Clinical Cancer Research (SAKK)
Search for other papers by for the Swiss Group for Clinical Cancer Research (SAKK) in
Google Scholar
PubMed Close

). Side effects such as hirsutism and other signs of virilisation in treated women and the evidence that testosterone may be easily converted to estrogens in the body led to the discontinuation of its use ( 5 ). These findings suggest that selective

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0174
Volume/Issue:
Volume 6: Issue 7
Open access
Lára Ósk Eggertsdóttir Claessen Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
Department of Emergency Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland

Search for other papers by Lára Ósk Eggertsdóttir Claessen in
Google Scholar
PubMed Close
,
Hafrún Kristjánsdóttir Physical Activity, Physical Education, Sport, and Health (PAPESH) Research Centre, Sports Science Department, School of Social Sciences, Reykjavik University, Reykjavik, Iceland

Search for other papers by Hafrún Kristjánsdóttir in
Google Scholar
PubMed Close
,
María Kristín Jónsdóttir Mental Health Services, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland
Department of Psychology, School of Social Sciences, Reykjavik University, Reykjavik, Iceland

Search for other papers by María Kristín Jónsdóttir in
Google Scholar
PubMed Close
,
Sigrún Helga Lund deCODE Genetics, Inc/Amgen Inc., Reykjavik, Iceland
School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland

Search for other papers by Sigrún Helga Lund in
Google Scholar
PubMed Close
,
Ingunn Unnsteinsdóttir Kristensen Department of Psychology, School of Social Sciences, Reykjavik University, Reykjavik, Iceland

Search for other papers by Ingunn Unnsteinsdóttir Kristensen in
Google Scholar
PubMed Close
, and
Helga Ágústa Sigurjónsdóttir Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
Department of Medicine, Landspitali – The National University Hospital of Iceland, Reykjavik, Iceland

Search for other papers by Helga Ágústa Sigurjónsdóttir in
Google Scholar
PubMed Close

, s-prolactin, serum cortisol (s-cortisol), serum follicle-stimulating hormone (s-FSH), serum luteinizing hormone (s-LH), serum estrogen (s-estrogen) and serum progesterone (s-progesterone). If the first SBT was O-RV for each hormone ( Table 1 ), the

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0363
Volume/Issue:
Volume 13: Issue 2
Open access
Julia H Goedecke Non-communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa
Division of Exercise Science and Sport Medicine, Department of Human Biology, University of Cape Town, 3 Floor Sports Science Institute of South Africa Cape Town, South Africa

Search for other papers by Julia H Goedecke in
Google Scholar
PubMed Close
,
Mehreen Tootla Division of Exercise Science and Sport Medicine, Department of Human Biology, University of Cape Town, 3 Floor Sports Science Institute of South Africa Cape Town, South Africa

Search for other papers by Mehreen Tootla in
Google Scholar
PubMed Close
, and
Dheshnie Keswell Division of Exercise Science and Sport Medicine, Department of Human Biology, University of Cape Town, 3 Floor Sports Science Institute of South Africa Cape Town, South Africa

Search for other papers by Dheshnie Keswell in
Google Scholar
PubMed Close

. International Journal of Obesity 2012 37 237 – 243 . ( https://doi.org/10.1038/ijo.2012.9 ) 2 Hevener AL Clegg DJ Mauvais-Jarvis F. Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome . Molecular and Cellular

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0531
Volume/Issue:
Volume 8: Issue 1
Open access
Carina Ankarberg-Lindgren Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Carina Ankarberg-Lindgren in
Google Scholar
PubMed Close
,
Aneta Gawlik Department of Pediatrics and Pediatric Endocrinology, Medical University of Silesia, School of Medicine, Katowice, Poland

Search for other papers by Aneta Gawlik in
Google Scholar
PubMed Close
,
Berit Kriström Department of Clinical Sciences/Pediatrics, Umeå University, Umeå, Sweden

Search for other papers by Berit Kriström in
Google Scholar
PubMed Close
,
Laura Mazzanti Pediatric Endocrinology and Rare Disease Unit, Department of Medical and Surgical Science, University of Bologna, Bologna, Italy

Search for other papers by Laura Mazzanti in
Google Scholar
PubMed Close
,
Elisabeth J Ruijgrok Department of Pharmacy, Erasmus Medical Center – Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands

Search for other papers by Elisabeth J Ruijgrok in
Google Scholar
PubMed Close
, and
Theo C J Sas Department of Pediatric Endocrinology, Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands
Diabeter, National Diabetes Care and Research Center, Rotterdam, the Netherlands

Search for other papers by Theo C J Sas in
Google Scholar
PubMed Close

Introduction Girls with hypogonadism require estrogen replacement therapy to induce puberty and maintain secondary sex characteristics, as well as to attain peak bone mass. These outcomes are achieved by starting with a low estradiol (E 2

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0025
Volume/Issue:
Volume 8: Issue 4
Open access
Andrew R Dismukes Department of Human Development and Family Studies, Iowa State University, Ames, Iowa, USA
Tulane University School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Tulane University, New Orleans, Louisiana, USA

Search for other papers by Andrew R Dismukes in
Google Scholar
PubMed Close
,
Vanessa J Meyer Department of Human Development and Family Studies, Iowa State University, Ames, Iowa, USA
Tulane University School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Tulane University, New Orleans, Louisiana, USA

Search for other papers by Vanessa J Meyer in
Google Scholar
PubMed Close
,
Elizabeth A Shirtcliff Department of Human Development and Family Studies, Iowa State University, Ames, Iowa, USA

Search for other papers by Elizabeth A Shirtcliff in
Google Scholar
PubMed Close
,
Katherine P Theall Tulane University School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Tulane University, New Orleans, Louisiana, USA

Search for other papers by Katherine P Theall in
Google Scholar
PubMed Close
,
Kyle C Esteves Tulane University School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Tulane University, New Orleans, Louisiana, USA

Search for other papers by Kyle C Esteves in
Google Scholar
PubMed Close
, and
Stacy S Drury Tulane University School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Tulane University, New Orleans, Louisiana, USA

Search for other papers by Stacy S Drury in
Google Scholar
PubMed Close

fluctuates in response to social stressors ( 2 ). Unlike other steroid hormones that have specific receptors, DHEA binds to a range of receptors, including the estrogen receptor ( 3 ). DHEA serves as a prohormone for estrogen and testosterone and can broadly

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0007
Volume/Issue:
Volume 5: Issue 3
Open access
Diana-Alexandra Ertl Department of Pulmonology, Allergology and Endocrinology, University Clinic for Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

Search for other papers by Diana-Alexandra Ertl in
Google Scholar
PubMed Close
,
Andreas Gleiss Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria

Search for other papers by Andreas Gleiss in
Google Scholar
PubMed Close
,
Katharina Schubert Department of Pulmonology, Allergology and Endocrinology, University Clinic for Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

Search for other papers by Katharina Schubert in
Google Scholar
PubMed Close
,
Caroline Culen Department of Pulmonology, Allergology and Endocrinology, University Clinic for Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

Search for other papers by Caroline Culen in
Google Scholar
PubMed Close
,
Peer Hauck Pediatric Heart Center Vienna, University Clinic for Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

Search for other papers by Peer Hauck in
Google Scholar
PubMed Close
,
Johannes Ott Clinic Division for Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria

Search for other papers by Johannes Ott in
Google Scholar
PubMed Close
,
Alois Gessl Division of Endocrinology, University Clinic of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Alois Gessl in
Google Scholar
PubMed Close
, and
Gabriele Haeusler Department of Pulmonology, Allergology and Endocrinology, University Clinic for Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

Search for other papers by Gabriele Haeusler in
Google Scholar
PubMed Close

considerable proportion of the women with induced puberty no longer had any estrogen therapy ( 14 ). The reasons for insufficient medical care for women with TS in adulthood may be manifold. Transfer from pediatric to adult medical care is a challenge for

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0053
Volume/Issue:
Volume 7: Issue 4
Open access
Christos Tsatsanis Department of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Crete, Greece
Molecular Reproductive Research Group, Department of Translational Medicine, Lund University, Malmö, Sweden
Institute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece

Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed Close
,
Angel Elenkov Molecular Reproductive Research Group, Department of Translational Medicine, Lund University, Malmö, Sweden
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden

Search for other papers by Angel Elenkov in
Google Scholar
PubMed Close
,
Irene Leijonhufvud Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden

Search for other papers by Irene Leijonhufvud in
Google Scholar
PubMed Close
,
Katerina Vaporidi Molecular Reproductive Research Group, Department of Translational Medicine, Lund University, Malmö, Sweden

Search for other papers by Katerina Vaporidi in
Google Scholar
PubMed Close
,
Åsa Tivesten Wallenberg Laboratory for Cardiovascular and Metabolic Research, Institute of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Åsa Tivesten in
Google Scholar
PubMed Close
, and
Aleksander Giwercman Molecular Reproductive Research Group, Department of Translational Medicine, Lund University, Malmö, Sweden
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden

Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed Close

to be regulated by sex hormones. BAFF suppression by testosterone has been demonstrated in animal studies and indirectly in humans when comparing men with high and low testosterone levels ( 4 ). In contrast, estrogens have been demonstrated to induce

Article Type:
Research Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-22-0456
Volume/Issue:
Volume 12: Issue 3
Open access
Margarida Brito Department of Medical Oncology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Search for other papers by Margarida Brito in
Google Scholar
PubMed Close
,
Susana Prazeres Department of Clinical Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Search for other papers by Susana Prazeres in
Google Scholar
PubMed Close
, and
Marta Malheiros Department of Clinical Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

Search for other papers by Marta Malheiros in
Google Scholar
PubMed Close

Introduction Fulvestrant was the first selective estrogen receptor degrader (SERD) ( 1 ) to enter clinical practice and represents, alone or in combination with targeted therapies, a key compound for endocrine advanced breast cancer (ABC). As

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-23-0178
Volume/Issue:
Volume 12: Issue 11
Open access